MEI Pharma, Inc.
San Diego
California
United States
381 articles about MEI Pharma, Inc.
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reports Fiscal Year 2015 Results
9/2/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Wedbush PacGrow Healthcare Conference
8/4/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Cantor Fitzgerald Healthcare Conference
7/1/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reports Updated Results From Phase II Study Of Pracinostat And Azacitidine In Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
6/12/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Bank of America Merrill Lynch Health Care Conference
5/6/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.)'s Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity In Combination With Tyrosine-Kinase Inhibitor In Pre-Clinical Studies
5/4/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Needham Healthcare Conference
4/1/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces Top-Line Data From Randomized Phase II Clinical Study Of Pracinostat In Front-Line Myelodysplastic Syndrome
3/23/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Cowen and Company Health Care Conference
2/26/2015
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reaches Response Milestone In Phase 2 Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome
12/22/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Completes Public Offering of Common Stock
12/18/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces Pricing Of Public Offering Of Common Stock
12/12/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces $45 Million Proposed Public Offering
12/11/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reports Significant Clinical Activity In Phase 2 Study Of Pracinostat In Front Line Acute Myeloid Leukemia
12/8/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces Election Of Pharmaceutical Industry Veteran Kevan Clemens To Board Of Directors
12/4/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Completes Enrollment In Phase 2 Study Of Pracinostat In Front Line Acute Myeloid Leukemia
12/2/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Host Analyst And Investor Event
12/1/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Host Annual Meeting Of Stockholders
11/26/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Stifel Healthcare Conference
11/12/2014
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reports Improved Response Rates In Phase 2 Study Of Pracinostat In Front Line Acute Myeloid Leukemia
11/6/2014